Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma

dc.contributor
Institut Català de la Salut
dc.contributor
[Errazquin R] Research Institute Hospital 12 de Octubre (Imas12), University Hospital 12 de Octubre, Madrid, Spain. Molecular Oncology Unit, CIEMAT (Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas), Madrid, Spain. [Carrasco E, Suñol A, Balmaña J] Hereditary Cancer Genetics Group, Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Del Marro S, Peral J, Ortiz J] Molecular Oncology Unit, CIEMAT (Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas), Madrid, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Carrasco López, Estela
dc.contributor.author
Del Marro, Sonia
dc.contributor.author
Suñol, Anna
dc.contributor.author
Peral, Jorge
dc.contributor.author
Ortiz, Jessica
dc.contributor.author
Balmaña Gelpí, Judith
dc.contributor.author
Errazquin, Ricardo
dc.date.accessioned
2025-10-25T05:37:14Z
dc.date.available
2025-10-25T05:37:14Z
dc.date.issued
2023-04-04T09:43:08Z
dc.date.issued
2023-04-04T09:43:08Z
dc.date.issued
2023-03-21
dc.identifier
Errazquin R, Carrasco E, Del Marro S, Suñol A, Peral J, Ortiz J, et al. Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma. Cancers. 2023 Mar 21;15(6):1871.
dc.identifier
2072-6694
dc.identifier
https://hdl.handle.net/11351/9297
dc.identifier
10.3390/cancers15061871
dc.identifier
36980757
dc.identifier.uri
http://hdl.handle.net/11351/9297
dc.description.abstract
Fanconi anemia; Cancer gene; Saliva
dc.description.abstract
Anèmia de Fanconi; Gen del càncer; Saliva
dc.description.abstract
Anemia de Fanconi; Gen del cáncer; Saliva
dc.description.abstract
Fanconi anemia (FA) patients display an exacerbated risk of oral squamous cell carcinoma (OSCC) and oral potentially malignant lesions (OPMLs) at early ages. As patients have defects in their DNA repair mechanisms, standard-of-care treatments for OSCC such as radiotherapy and chemotherapy, give rise to severe toxicities. New methods for early diagnosis are urgently needed to allow for treatment in early disease stages and achieve better clinical outcomes. We conducted a prospective, longitudinal study wherein liquid biopsies from sixteen patients with no clinical diagnoses of OPML and/or OSCC were analyzed for the presence of mutations in cancer genes. The DNA from saliva and plasma were sequentially collected and deep-sequenced, and the clinical evaluation followed over a median time of approximately 2 years. In 9/16 FA patients, we detected mutations in cancer genes (mainly TP53) with minor allele frequencies (MAF) of down to 0.07%. Importantly, all patients that had mutations and clinical follow-up data after mutation detection (n = 6) developed oral precursor lesions or OSCC. The lead-time between mutation detection and tumor diagnosis ranged from 23 to 630 days. Strikingly, FA patients without mutations displayed a significantly lower risk of developing precursor lesions or OSCCs. Therefore, our diagnostic approach could help to stratify FA patients into risk groups, which would allow for closer surveillance for OSCCs or precursor lesions.
dc.description.abstract
This study was funded by Instituto de Salud Carlos III (ISCIII) through the projects CB16/12/00228/CIBERONC, PI18/00263 and P121/00208; co-funded by FEDER and the European Union; and funded by a grant from the Spanish Fundacion Anemia de Fanconi. J.P. was supported by a FEDER co-funded grant (ref. PEJ2018-002040-A) from the Ministerio de Ciencia e Innovación. J.O. was supported by a FEDER co-funded grant (ref. PEJ-2019-TL_BMD-12905) from the Comunidad de Madrid. The funding sources were not involved in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
MDPI
dc.relation
Cancers;15(6)
dc.relation
https://doi.org/10.3390/cancers15061871
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Scientia
dc.subject
Anèmia de Fanconi
dc.subject
Boca - Càncer - Diagnòstic
dc.subject
Plasma sanguini
dc.subject
Càncer - Detecció precoç
dc.subject
DISEASES::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Mouth Neoplasms
dc.subject
Other subheadings::Other subheadings::/diagnosis
dc.subject
DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Anemia::Anemia, Aplastic::Anemia, Hypoplastic, Congenital::Fanconi Anemia
dc.subject
ANATOMY::Fluids and Secretions::Body Fluids::Blood::Plasma
dc.subject
ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello::neoplasias de la boca
dc.subject
Otros calificadores::Otros calificadores::/diagnóstico
dc.subject
ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::anemia::anemia aplásica::anemia hipoplásica congénita::anemia de Fanconi
dc.subject
ANATOMÍA::líquidos y secreciones::líquidos corporales::sangre::plasma
dc.title
Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)